ALK1 heterozygosity increases extracellular matrix protein expression, proliferation and migration in fibroblasts

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 6, 2014, Pages 1111-1122

  Muñoz Félix, José M ^a,b   Perretta Tejedor, Nuria ^a,b,c   Eleno, Nélida ^a,b   López Novoa, José M ^a,b   Martínez Salgado, Carlos ^a,b,c  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA IBSAL   (Spain)

^c HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

ALK1; Extracellular matrix; Fibrosis; Migration; Proliferation; Smads

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; COLLAGEN TYPE 1; CONNECTIVE TISSUE GROWTH FACTOR; FIBRONECTIN; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CELL STIMULATION; EMBRYO; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FIBROBLAST; FOCAL ADHESION; GENOTYPE; HAPLOINSUFFICIENCY; HETEROZYGOSITY; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WOUND HEALING;

ALK1; EXTRACELLULAR MATRIX; FIBROSIS; MIGRATION; PROLIFERATION; SMADS;

ACTIVIN RECEPTORS, TYPE I; ANIMALS; BLOTTING, WESTERN; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN TYPE I; CONNECTIVE TISSUE GROWTH FACTOR; EMBRYO, MAMMALIAN; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FIBROBLASTS; FIBRONECTINS; FLUORESCENT ANTIBODY TECHNIQUE; HETEROZYGOTE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHORYLATION; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 84895983200     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.02.017     Document Type: Article

References (53)

1. Zeisberg M., Kalluri R. Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis. Am. J. Physiol. Cell Physiol. 2013, 304:C216-C225.
2. Fuentes-Calvo I., Blazquez-Medela A.M., Eleno N., Santos E., Lopez-Novoa J.M., Martinez-Salgado C. H-Ras isoform modulates extracellular matrix synthesis, proliferation, and migration in fibroblasts. Am. J. Physiol. Cell Physiol. 2012, 302:C686-C697.
3. Pericacho M., Velasco S., Prieto M., Llano E., Lopez-Novoa J.M., Rodriguez-Barbero A. Endoglin haploinsufficiency promotes fibroblast accumulation during wound healing through Akt activation. PLoS One 2013, 8:e54687.
4. Wang W., Koka V., Lan H.Y. Transforming growth factor-beta and Smad signalling in kidney diseases. Nephrology (Carlton) 2005, 10:48-56.
5. Dooley S., Hamzavi J., Breitkopf K., Wiercinska E., Said H.M., Lorenzen J., Ten Dijke P., Gressner A.M. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology 2003, 125:178-191.
6. Morris E., Chrobak I., Bujor A., Hant F., Mummery C., Ten Dijke P., Trojanowska M. Endoglin promotes TGF-beta/Smad1 signaling in scleroderma fibroblasts. J. Cell. Physiol. 2011, 226:3340-3348.
7. Martinez-Salgado C., Fuentes-Calvo I., Garcia-Cenador B., Santos E., Lopez-Novoa J.M. Involvement of H- and N-Ras isoforms in transforming growth factor-beta1-induced proliferation and in collagen and fibronectin synthesis. Exp. Cell Res. 2006, 312:2093-2106.
8. Kocic J., Bugarski D., Santibanez J.F. SMAD3 is essential for transforming growth factor-beta1-induced urokinase type plasminogen activator expression and migration in transformed keratinocytes. Eur. J. Cancer 2012, 48:1550-1557.
9. Meng X.M., Huang X.R., Xiao J., Chen H.Y., Zhong X., Chung A.C., Lan H.Y. Diverse roles of TGF-beta receptor II in renal fibrosis and inflammation in vivo and in vitro. J. Pathol. 2012, 227:175-188.
10. Lebrin F., Deckers M., Bertolino P., Ten Dijke P. TGF-beta receptor function in the endothelium. Cardiovasc. Res. 2005, 65:599-608.
11. Lebrin F., Goumans M.J., Jonker L., Carvalho R.L., Valdimarsdottir G., Thorikay M., Mummery C., Arthur H.M., ten Dijke P. Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction. EMBO J. 2004, 23:4018-4028.
12. Gonzalez-Nunez M., Munoz-Felix J.M., Lopez-Novoa J.M. The ALK-1/Smad1 pathway in cardiovascular physiopathology. A new target for therapy?. Biochim. Biophys. Acta 2013, 1832:1492-1510.
13. Goumans M.J., Valdimarsdottir G., Itoh S., Lebrin F., Larsson J., Mummery C., Karlsson S., ten Dijke P. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol. Cell 2003, 12:817-828.
14. Goumans M.J., Lebrin F., Valdimarsdottir G. Controlling the angiogenic switch: a balance between two distinct TGF-b receptor signaling pathways. Trends Cardiovasc. Med. 2003, 13:301-307.
15. Bertolino P., Deckers M., Lebrin F., ten Dijke P. Transforming growth factor-beta signal transduction in angiogenesis and vascular disorders. Chest 2005, 128:585S-590S.
16. Velasco S., Alvarez-Munoz P., Pericacho M., Dijke P.T., Bernabeu C., Lopez-Novoa J.M., Rodriguez-Barbero A. l- and S-endoglin differentially modulate TGFbeta1 signaling mediated by ALK1 and ALK5 in L6E9 myoblasts. J. Cell Sci. 2008, 121:913-919.
17. Munoz-Felix J.M., Gonzalez-Nunez M., Lopez-Novoa J.M. ALK1-Smad1/5 signaling pathway in fibrosis development: friend or foe?. Cytokine Growth Factor Rev. 2013, 24:523-537.
18. Blaney Davidson E.N., Remst D.F., Vitters E.L., van Beuningen H.M., Blom A.B., Goumans M.J., van den Berg W.B., van der Kraan P.M. Increase in ALK1/ALK5 ratio as a cause for elevated MMP-13 expression in osteoarthritis in humans and mice. J. Immunol. 2009, 182:7937-7945.
19. Finnson K.W., Parker W.L., ten Dijke P., Thorikay M., Philip A. ALK1 opposes ALK5/Smad3 signaling and expression of extracellular matrix components in human chondrocytes. J. Bone Miner. Res. 2008, 23:896-906.
20. Weng H.L., Ciuclan L., Liu Y., Hamzavi J., Godoy P., Gaitantzi H., Kanzler S., Heuchel R., Ueberham U., Gebhardt R., Breitkopf K., Dooley S. Profibrogenic transforming growth factor-beta/activin receptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytes. Hepatology 2007, 46:1257-1270.
21. Wiercinska E., Wickert L., Denecke B., Said H.M., Hamzavi J., Gressner A.M., Thorikay M., ten Dijke P., Mertens P.R., Breitkopf K., Dooley S. Id1 is a critical mediator in TGF-beta-induced transdifferentiation of rat hepatic stellate cells. Hepatology 2006, 43:1032-1041.
22. Pannu J., Nakerakanti S., Smith E., ten Dijke P., Trojanowska M. Transforming growth factor-beta receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways. J. Biol. Chem. 2007, 282:10405-10413.
23. Scharpfenecker M., Floot B., Korlaar R., Russell N.S., Stewart F.A. ALK1 heterozygosity delays development of late normal tissue damage in the irradiated mouse kidney. Radiother. Oncol. 2011, 99:349-355.
24. Munoz-Felix J.M., Lopez-Novoa J.M., Martinez-Salgado C. Heterozygous disruption of activin receptor-like kinase 1 is associated with increased renal fibrosis in a mouse model of obstructive nephropathy. Kidney Int. 2014, 85:319-332.
25. Oh S.P., Seki T., Goss K.A., Imamura T., Yi Y., Donahoe P.K., Li L., Miyazono K., ten Dijke P., Kim S., Li E. Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:2626-2631.
26. Fuentes-Calvo I., Blazquez-Medela A.M., Santos E., Lopez-Novoa J.M., Martinez-Salgado C. Analysis of k-ras nuclear expression in fibroblasts and mesangial cells. PLoS One 2010, 5:e8703.
27. Laping N.J., Grygielko E., Mathur A., Butter S., Bomberger J., Tweed C., Martin W., Fornwald J., Lehr R., Harling J., Gaster L., Callahan J.F., Olson B.A. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Mol. Pharmacol. 2002, 62:58-64.
28. Jinnin M., Ihn H., Tamaki K. Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression. Mol. Pharmacol. 2006, 69:597-607.
29. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W., Lipman D.J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997, 25:3389-3402.
30. Sancho-Martinez S.M., Piedrafita F.J., Cannata-Andia J.B., Lopez-Novoa J.M., Lopez-Hernandez F.J. Necrotic concentrations of cisplatin activate the apoptotic machinery but inhibit effector caspases and interfere with the execution of apoptosis. Toxicol. Sci. 2011, 122:73-85.
31. Strutz F., Zeisberg M. Renal fibroblasts and myofibroblasts in chronic kidney disease. J. Am. Soc. Nephrol. 2006, 17:2992-2998.
32. Gressner O.A., Lahme B., Siluschek M., Rehbein K., Weiskirchen R., Gressner A.M. Connective tissue growth factor is a Smad2 regulated amplifier of transforming growth factor beta actions in hepatocytes-but without modulating bone morphogenetic protein 7 signaling. Hepatology 2009, 49:2021-2030.
33. Finnson K.W., Parker W.L., Chi Y., Hoemann C.D., Goldring M.B., Antoniou J., Philip A. Endoglin differentially regulates TGF-beta-induced Smad2/3 and Smad1/5 signalling and its expression correlates with extracellular matrix production and cellular differentiation state in human chondrocytes. Osteoarthritis Cartilage 2010, 18:1518-1527.
34. Scherner O., Meurer S.K., Tihaa L., Gressner A.M., Weiskirchen R. Endoglin differentially modulates antagonistic transforming growth factor-beta1 and BMP-7 signaling. J. Biol. Chem. 2007, 282:13934-13943.
35. Pannu J., Asano Y., Nakerakanti S., Smith E., Jablonska S., Blaszczyk M., ten Dijke P., Trojanowska M. Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate. Arthritis Rheum. 2008, 58:2528-2537.
36. Goumans M.J., Valdimarsdottir G., Itoh S., Rosendahl A., Sideras P., ten Dijke P. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J. 2002, 21:1743-1753.
37. Verrecchia F., Mauviel A. Transforming growth factor-beta and fibrosis. World J. Gastroenterol. 2007, 13:3056-3062.
38. Hocevar B.A., Brown T.L., Howe P.H. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J. 1999, 18:1345-1356.
39. Isono M., Chen S., Hong S.W., Iglesias-de la Cruz M.C., Ziyadeh F.N. Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells. Biochem. Biophys. Res. Commun. 2002, 296:1356-1365.
40. Sato M., Muragaki Y., Saika S., Roberts A.B., Ooshima A. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J. Clin. Invest. 2003, 112:1486-1494.
41. Meng X.M., Huang X.R., Chung A.C., Qin W., Shao X., Igarashi P., Ju W., Bottinger E.P., Lan H.Y. Smad2 protects against TGF-beta/Smad3-mediated renal fibrosis. J. Am. Soc. Nephrol. 2010, 21:1477-1487.
42. Grande M.T., Fuentes-Calvo I., Arevalo M., Heredia F., Santos E., Martinez-Salgado C., Rodriguez-Puyol D., Nieto M.A., Lopez-Novoa J.M. Deletion of H-Ras decreases renal fibrosis and myofibroblast activation following ureteral obstruction in mice. Kidney Int. 2010, 77:509-518.
43. Truong L.D., Petrusevska G., Yang G., Gurpinar T., Shappell S., Lechago J., Rouse D., Suki W.N. Cell apoptosis and proliferation in experimental chronic obstructive uropathy. Kidney Int. 1996, 50:200-207.
44. Haberstroh U., Zahner G., Disser M., Thaiss F., Wolf G., Stahl R.A. TGF-beta stimulates rat mesangial cell proliferation in culture: role of PDGF beta-receptor expression. Am. J. Physiol. 1993, 264:F199-F205.
45. Brown K.A., Pietenpol J.A., Moses H.L. A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling. J. Cell. Biochem. 2007, 101:9-33.
46. Hjelmeland M.D., Hjelmeland A.B., Sathornsumetee S., Reese E.D., Herbstreith M.H., Laping N.J., Friedman H.S., Bigner D.D., Wang X.F., Rich J.N. SB-431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma cell line proliferation and motility. Mol. Cancer Ther. 2004, 3:737-745.
47. Li J., Li P., Zhang Y., Li G.B., Zhou Y.G., Yang K., Dai S.S. c-Ski inhibits the proliferation of vascular smooth muscle cells via suppressing Smad3 signaling but stimulating p38 pathway. Cell. Signal. 2013, 25:159-167.
48. Dobaczewski M., Bujak M., Li N., Gonzalez-Quesada C., Mendoza L.H., Wang X.F., Frangogiannis N.G. Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction. Circ. Res. 2010, 107:418-428.
49. Meran S., Thomas D.W., Stephens P., Enoch S., Martin J., Steadman R., Phillips A.O. Hyaluronan facilitates transforming growth factor-beta1-mediated fibroblast proliferation. J. Biol. Chem. 2008, 283:6530-6545.
50. Cheon S.S., Wei Q., Gurung A., Youn A., Bright T., Poon R., Whetstone H., Guha A., Alman B.A. Beta-catenin regulates wound size and mediates the effect of TGF-beta in cutaneous healing. FASEB J. 2006, 20:692-701.
51. Lee N.Y., Ray B., How T., Blobe G.C. Endoglin promotes transforming growth factor beta-mediated Smad 1/5/8 signaling and inhibits endothelial cell migration through its association with GIPC. J. Biol. Chem. 2008, 283:32527-32533.
52. Ray B.N., Lee N.Y., How T., Blobe G.C. ALK5 phosphorylation of the endoglin cytoplasmic domain regulates Smad1/5/8 signaling and endothelial cell migration. Carcinogenesis 2010, 31:435-441.
53. David L., Mallet C., Vailhe B., Lamouille S., Feige J.J., Bailly S. Activin receptor-like kinase 1 inhibits human microvascular endothelial cell migration: potential roles for JNK and ERK. J. Cell. Physiol. 2007, 213:484-489.